Induction of blocks in nuclear divisions and overcondensation of meiotic chromosomes with cycloheximide during conjugation of Tetrahymena thermophila.
During conjugation, the micronucleus of Tetrahymena thermophila undergoes five consecutive nuclear divisions: meiosis, third prezygotic division (pregamic mitosis) and two postzygotic mitoses of the synkaryon. The four products of the synkaryon differentiate into macronuclear anlagen and new micronuclei and the old macronucleus is resorbed. The protein synthesis inhibitor cycloheximide, applied during conjugation, induced several developmental blocks. Pairs shifted to the drug during early meiotic prophase (stages I-III) were arrested at prophase. Cycloheximide applied to cells at pachytene (stages IV-VI) to metaphase arrested the conjugants at the stage of modified prometaphase/metaphase with overcondensed, swollen bivalents. In contrast to other systems, in the presence of cycloheximide, separation of chromatids, decondensation of chromosomes and exit from metaphase I were inhibited in both diploid and haploid cells. Pairs shifted to the drug after metaphase I were arrested at postmeiotic interphase after completing one nuclear cycle. The same rule applied to the subsequent cycle; then cells were arrested at the stage of pronuclei, and those pairs with functional pronuclei and synkarya were arrested at the stage of two products of the first postzygotic division (pronuclei were not arrested in nuclear transfer and karyogamy). Only pairs with two products of the first postzygotic division were arrested at the same stage after the cycloheximide treatment. Pairs shifted to cycloheximide during the second postzygotic division were arrested in development of macronuclear anlagen and resorption of old macronuclei. The postmeiotic conjugants pulse-treated with cycloheximide (2 h) yielded heterokaryons retaining parental macronuclei (i.e. they exhibited macronuclear retention).
Kaczanowski
A
A
Department of Cytophysiology, University of Warsaw, Poland.
Kaczanowska
J
J
D000705:Anaphase; D000818:Animals; D002875:Chromosomes; D003433:Crosses, Genetic; D003513:Cycloheximide / Q000494:pharmacology*; D003609:Dactinomycin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D007399:Interphase; D008540:Meiosis / Q000187:drug effects / Q000502:physiology*; D008677:Metaphase; D048631:Micronucleus, Germline / Q000187:drug effects / Q000502:physiology*; D009154:Mutation; D011418:Prophase; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology*; D016808:Tetrahymena thermophila / Q000187:drug effects / Q000502:physiology*
D011500:Protein Synthesis Inhibitors; D003609:Dactinomycin; D003513:Cycloheximide